| 1 | Pleural Neoplasms | 44.8% |
| 2 | Tracheal Neoplasms | 42.6% |
| 3 | Pleural Effusion, Malignant | 33.8% |
| 4 | Pneumonia | 33.6% |
| 5 | Lobar Pneumonia | 33.6% |
| 6 | Respiratory Distress Syndrome, Adult | 33.6% |
| 7 | Pneumonitis | 33.6% |
| 8 | Bronchitis | 32.4% |
| 9 | Bronchitis, Chronic | 30.6% |
| 10 | Idiopathic Pulmonary Fibrosis | 29.7% |
| 11 | Bronchopneumonia | 29.7% |
| 12 | Pleuropneumonia | 29% |
| 13 | Lung Diseases, Fungal | 28.1% |
| 14 | Pneumoconiosis | 28.1% |
| 15 | Atelectasis | 27.8% |
| 16 | Pulmonary Hypertension | 27.8% |
| 17 | Pulmonary Alveolar Proteinosis | 27.8% |
| 18 | Pulmonary Edema | 27.8% |
| 19 | Pulmonary Fibrosis | 27.8% |
| 20 | Hamman-Rich syndrome | 27.8% |
| 21 | Lung Diseases, Interstitial | 27.8% |
| 22 | Lung Diseases, Obstructive | 27.8% |
| 23 | Respiratory Distress Syndrome, Newborn | 27.7% |
| 24 | Lung Abscess | 27.6% |
| 25 | Tuberculosis, Pulmonary | 27.5% |
| 26 | Asthma | 27.5% |
| 27 | Bronchiolitis | 24.7% |
| 28 | Aspiration Pneumonia | 24.5% |
| 29 | Tracheobronchomegaly | 23.9% |
| 30 | Laryngeal neoplasm | 23.5% |
| 31 | Radiation Pneumonitis | 23.3% |
| 32 | Radiation Fibrosis | 23.3% |
| 33 | Asbestosis | 22.6% |
| 34 | Berylliosis | 22.6% |
| 35 | Silicosis | 22.6% |
| 36 | Pleurisy | 22.4% |
| 37 | Tracheitis | 22.4% |
| 38 | Lung Injury | 22.4% |
| 39 | Hepatopulmonary Syndrome | 22.4% |
| 40 | Pulmonary Embolism | 21.9% |
| 41 | Pulmonary Eosinophilia | 21.8% |
| 42 | Eosinophilic Pneumonia | 21.8% |
| 43 | Bronchial Diseases | 21.6% |
| 44 | Pleural Diseases | 21.6% |
| 45 | Respiration Disorders | 21.6% |
| 46 | Thoracic Diseases | 21.6% |
| 47 | Tracheal Diseases | 21.6% |
| 48 | Pneumonia, Viral | 21.1% |
| 49 | Pneumonia, Bacterial | 20.6% |
| 50 | Nose Neoplasms | 20.5% |
| 51 | Chronic Obstructive Airway Disease | 20.5% |
| 52 | Middle Lobe Syndrome | 20.5% |
| 53 | Acute Lung Injury | 20.5% |
| 54 | Hyaline Membrane Disease | 20.2% |
| 55 | Aspergillosis, Allergic Bronchopulmonary | 20.2% |
| 56 | Pneumonia, Lipid | 20.1% |
| 57 | Granuloma, Laryngeal | 19% |
| 58 | Bronchiolitis Obliterans | 18.7% |
| 59 | Laryngitis | 18.7% |
| 60 | Rhinitis | 18.7% |
| 61 | Vocal Cord Dysfunction | 18.7% |
| 62 | Bronchial Fistula | 18.4% |
| 63 | Scimitar Syndrome | 18.3% |
| 64 | Hemoptysis | 18.3% |
| 65 | Acute Chest Syndrome | 17.9% |
| 66 | Laryngeal Diseases | 17.8% |
| 67 | Nose Diseases | 17.8% |
| 68 | Paranasal Sinus Neoplasms | 17.6% |
| 69 | Meconium Aspiration Syndrome | 17.3% |
| 70 | Respiratory Tract Infections | 17.3% |
| 71 | Granuloma, Respiratory Tract | 17% |
| 72 | Respiratory Hypersensitivity | 17% |
| 73 | Respiratory Tract Fistula | 17% |
| 74 | Pulmonary Emphysema | 16.9% |
| 75 | Persistent Fetal Circulation Syndrome | 16.6% |
| 76 | Histiocytosis, Langerhans-Cell | 16.3% |
| 77 | Pulmonary Aspergillosis | 16.3% |
| 78 | Bronchopulmonary Aspergillosis | 16.3% |
| 79 | Sarcoidosis, Pulmonary | 16.2% |
| 80 | Pulmonary Infarction | 16.2% |
| 81 | Cystic Fibrosis | 16.1% |
| 82 | Sinusitis | 16% |
| 83 | Choanal Atresia | 15.9% |
| 84 | Laryngocele | 15.9% |
| 85 | Farmer's Lung | 15.4% |
| 86 | Thymus Neoplasms | 14.5% |
| 87 | Maxillary Sinus Neoplasms | 14.4% |
| 88 | Altitude Sickness | 13.9% |
| 89 | Bronchospasm | 13.9% |
| 90 | Bronchiectasis | 13.9% |
| 91 | Chylothorax | 13.9% |
| 92 | Hydropneumothorax | 13.9% |
| 93 | Hydrothorax | 13.9% |
| 94 | Pneumothorax | 13.9% |
| 95 | Respiratory Insufficiency | 13.9% |
| 96 | Tracheal Stenosis | 13.9% |
| 97 | Bronchial Hyperreactivity | 13.9% |
| 98 | Respiratory Depression | 13.9% |
| 99 | Respiratory Failure | 13.9% |
| 100 | Laryngospasm | 13.6% |
| 101 | Bronchopulmonary Dysplasia | 13.5% |
| 102 | Asthma, Exercise-Induced | 13.4% |
| 103 | Status Asthmaticus | 13.4% |
| 104 | Granulomatosis with polyangiitis | 13.4% |
| 105 | Blastomycosis | 13.4% |
| 106 | Abdominal Neoplasms | 13% |
| 107 | Head and Neck Neoplasms | 13% |
| 108 | Soft Tissue Neoplasms | 13% |
| 109 | Bronchial Neoplasms | 12.5% |
| 110 | Primary Ciliary Dyskinesia | 12.2% |
| 111 | Asthma, Occupational | 11.9% |
| 112 | Mediastinal Cyst | 11.7% |
| 113 | Pericardial Cyst | 11.7% |
| 114 | Thymic Cyst | 11.7% |
| 115 | Anti-Glomerular Basement Membrane Disease | 11.5% |
| 116 | Transfusion-Related Acute Lung Injury | 11.4% |
| 117 | Granuloma, Lethal Midline | 11.2% |
| 118 | Laryngeal Edema | 11.2% |
| 119 | Nose Deformities, Acquired | 11.2% |
| 120 | Respiratory Aspiration | 11.2% |
| 121 | Invasive Pulmonary Aspergillosis | 11.2% |
| 122 | Apnea | 11% |
| 123 | Cheyne-Stokes Respiration | 11% |
| 124 | Common Cold | 11% |
| 125 | Dyspnea | 11% |
| 126 | Hemothorax | 11% |
| 127 | Hyperventilation | 11% |
| 128 | Influenza | 11% |
| 129 | Mouth Breathing | 11% |
| 130 | Tachypnea | 11% |
| 131 | Catarrh | 11% |
| 132 | Severe Acute Respiratory Syndrome | 10.9% |
| 133 | Laryngopharyngeal Reflux | 10.9% |
| 134 | Rhinoscleroma | 10.9% |
| 135 | Lung diseases | 10.8% |
| 136 | Digestive System Neoplasms | 10.8% |
| 137 | Endocrine Gland Neoplasms | 10.8% |
| 138 | Eye Neoplasms | 10.8% |
| 139 | Nervous System Neoplasms | 10.8% |
| 140 | Hoarseness | 10.5% |
| 141 | Bone neoplasms | 10.5% |
| 142 | Skin Neoplasms | 10.5% |
| 143 | Hematologic Neoplasms | 10.5% |
| 144 | Hay fever | 10.5% |
| 145 | Rhinitis, Allergic, Perennial | 10.5% |
| 146 | Splenic Neoplasms | 10.3% |
| 147 | Airway Obstruction | 10.3% |
| 148 | Choking | 10.3% |
| 149 | Epiglottitis | 10.3% |
| 150 | Mediastinitis | 10.3% |
| 151 | Asthma, Aspirin-Induced | 10.1% |
| 152 | Kartagener Syndrome | 9.9% |
| 153 | Thymoma | 9.6% |
| 154 | Pharyngitis | 9.4% |
| 155 | Laryngostenosis | 9.2% |
| 156 | Nasal Polyps | 9.2% |
| 157 | Lung Neoplasms | 9.2% |
| 158 | Pertussis | 9.1% |
| 159 | Parathyroid Neoplasms | 8.9% |
| 160 | Peritoneal Neoplasms | 8.9% |
| 161 | Thyroid Neoplasm | 8.9% |
| 162 | Thyroid carcinoma | 8.9% |
| 163 | Eosinophilic Granuloma | 8.4% |
| 164 | Multiple Endocrine Neoplasia | 8.2% |
| 165 | Croup | 8.2% |
| 166 | Mediastinal Emphysema | 8.2% |
| 167 | Rhinitis, Vasomotor | 8.2% |
| 168 | Hypoventilation | 8.2% |
| 169 | Acidosis, Respiratory | 8.1% |
| 170 | Alkalosis, Respiratory | 8.1% |
| 171 | Hamartoma | 8.1% |
| 172 | Neoplasms, Hormone-Dependent | 8.1% |
| 173 | Neoplasms, Multiple Primary | 8.1% |
| 174 | Paraneoplastic Syndromes | 8.1% |
| 175 | Precancerous Conditions | 8.1% |
| 176 | Sleep Apnea Syndromes | 8.1% |
| 177 | Neoplasms, Second Primary | 8.1% |
| 178 | Paraneoplastic Encephalomyelitis | 8.1% |
| 179 | Voice Disorders | 8% |
| 180 | Voice Disturbance | 8% |
| 181 | Mammary Neoplasms, Experimental | 8% |
| 182 | Epistaxis | 7.9% |
| 183 | Pancreatic Neoplasm | 7.8% |
| 184 | Retroperitoneal Neoplasms | 7.7% |
| 185 | Acanthoma | 7.4% |
| 186 | Laryngomalacia | 6.9% |
| 187 | Vocal Cord Paralysis | 6.8% |
| 188 | Tonsillitis | 6.8% |
| 189 | Dyspnea, Paroxysmal | 6.7% |
| 190 | Respiratory Paralysis | 6.7% |
| 191 | Multiple Pulmonary Nodules | 6.7% |
| 192 | Sleep Apnea, Obstructive | 6.7% |
| 193 | Sleep Apnea, Central | 6.7% |
| 194 | Cyst | 6.5% |
| 195 | Neoplastic Processes | 6.5% |
| 196 | Neoplastic Syndromes, Hereditary | 6.5% |
| 197 | Pregnancy Complications, Neoplastic | 6.5% |
| 198 | Neoplasms, Experimental | 6.4% |
| 199 | Esophageal Neoplasms | 6.3% |
| 200 | Mouth Neoplasms | 6.2% |
| 201 | Central Nervous System Neoplasms | 6.2% |
| 202 | Vascular Neoplasms | 6.2% |
| 203 | Genital Neoplasms, Female | 6.1% |
| 204 | Breast Neoplasms, Male | 6.1% |
| 205 | Triple Negative Breast Neoplasms | 6.1% |
| 206 | Carcinoma, Lobular | 5.9% |
| 207 | Aphonia | 5.8% |
| 208 | Retropharyngeal Abscess | 5.8% |
| 209 | Dysphonia | 5.8% |
| 210 | Thyroid Nodule | 5.7% |
| 211 | Bronchomalacia | 5.7% |
| 212 | Tracheomalacia | 5.7% |
| 213 | Testicular Neoplasms | 5.6% |
| 214 | Neoplasms, Radiation-Induced | 5.3% |
| 215 | Adrenal Gland Neoplasms | 5.2% |
| 216 | Gastrointestinal Neoplasms | 5.2% |
| 217 | Genital Neoplasms, Male | 5.2% |
| 218 | Liver neoplasms | 5.2% |
| 219 | Uveal Neoplasms | 5.2% |
| 220 | Urologic Neoplasms | 5.1% |
| 221 | Sebaceous Gland Neoplasms | 5.1% |
| 222 | Spinal Neoplasms | 5.1% |
| 223 | Bone Marrow Neoplasms | 5.1% |
| 224 | Nasopharyngitis | 5.1% |
| 225 | Multiple Endocrine Neoplasia Type 1 | 5% |
| 226 | Meningioma | 5% |
| 227 | Carcinoma, Pancreatic Ductal | 4.9% |
| 228 | Carcinoma, Ehrlich Tumor | 4.8% |
| 229 | Dermoid Cyst | 4.8% |
| 230 | Carcinoma, Lewis Lung | 4.8% |
| 231 | Carcinoma 256, Walker | 4.8% |
| 232 | Peritonsillar Abscess | 4.7% |
| 233 | Liver Neoplasms, Experimental | 4.6% |
| 234 | Trophoblastic Neoplasms | 4.6% |
| 235 | Leukemia, Experimental | 4.5% |
| 236 | Erythroplasia | 4.3% |
| 237 | Follicular cyst | 4.3% |
| 238 | leukemia | 4.3% |
| 239 | Mucocele | 4.3% |
| 240 | Neoplasms, Germ Cell and Embryonal | 4.3% |
| 241 | Neoplasms, Glandular and Epithelial | 4.3% |
| 242 | Pilonidal Cyst | 4.3% |
| 243 | Thyroglossal Cyst | 4.3% |
| 244 | Synovial Cyst | 4.3% |
| 245 | Germ Cell Cancer | 4.3% |
| 246 | Aberrant Crypt Foci | 4.3% |
| 247 | Leukoplakia, Oral | 4.3% |
| 248 | Paraneoplastic Cerebellar Degeneration | 4.3% |
| 249 | Tuberous Sclerosis | 4.3% |
| 250 | Neuroectodermal Tumors | 4.1% |
| 251 | Meningeal Neoplasms | 4.1% |
| 252 | Sarcoma, Experimental | 4% |
| 253 | Melanoma, Experimental | 4% |
| 254 | Leukemia, Radiation-Induced | 3.9% |
| 255 | Acoustic Neuroma | 3.9% |
| 256 | Neoplasms, Neuroepithelial | 3.9% |
| 257 | Gliomatosis cerebri | 3.9% |
| 258 | Palatal Neoplasms | 3.9% |
| 259 | Hepatocellular Adenoma | 3.8% |
| 260 | insulinoma | 3.8% |
| 261 | ovarian neoplasm | 3.8% |
| 262 | Nephroblastoma | 3.8% |
| 263 | Vipoma | 3.8% |
| 264 | Limbic Encephalitis | 3.7% |
| 265 | Pituitary Adenoma | 3.7% |
| 266 | Pituitary Neoplasms | 3.7% |
| 267 | Gastrinoma | 3.7% |
| 268 | Glucagonoma | 3.7% |
| 269 | Retinoblastoma | 3.7% |
| 270 | Leukoplakia | 3.5% |
| 271 | Lymphocele | 3.5% |
| 272 | Pancreatic Cyst | 3.5% |
| 273 | Barrett Esophagus | 3.4% |
| 274 | Breast Cyst | 3.4% |
| 275 | Ear Neoplasms | 3.4% |
| 276 | Eyelid Neoplasms | 3.4% |
| 277 | Histiocytic Disorders, Malignant | 3.4% |
| 278 | Actinic keratosis | 3.4% |
| 279 | Neoplasm Invasiveness | 3.4% |
| 280 | Neoplasm Metastasis | 3.4% |
| 281 | Neoplasm Recurrence, Local | 3.4% |
| 282 | Parovarian Cyst | 3.4% |
| 283 | Carcinogenesis | 3.4% |
| 284 | Myxoid cyst | 3.4% |
| 285 | Metastasis | 3.4% |
| 286 | Lambert-Eaton Myasthenic Syndrome | 3.4% |
| 287 | Carcinosarcoma | 3.4% |
| 288 | Hemangiosarcoma | 3.4% |
| 289 | Leukemia L1210 | 3.4% |
| 290 | Leukemia P388 | 3.4% |
| 291 | lymphangiosarcoma | 3.4% |
| 292 | Brain Neoplasms | 3.4% |
| 293 | Salivary Gland Neoplasms | 3.4% |
| 294 | Spinal Cord Neoplasms | 3.4% |
| 295 | Tongue Neoplasms | 3.4% |
| 296 | melanoma | 3.3% |
| 297 | Uterine Neoplasms | 3.3% |
| 298 | Vaginal Neoplasms | 3.3% |
| 299 | Vulvar Neoplasms | 3.3% |
| 300 | Uterine Cancer | 3.3% |
| 301 | Fallopian Tube Neoplasms | 3.3% |
| 302 | Prolactinoma | 3.3% |
| 303 | Growth Hormone-Secreting Pituitary Adenoma | 3.3% |
| 304 | Leydig Cell Tumor | 3.2% |
| 305 | Lymphomatoid Granulomatosis | 3.1% |
| 306 | Choriocarcinoma | 3.1% |
| 307 | Optic Nerve Glioma | 3.1% |
| 308 | Sarcoma 180 | 3% |
| 309 | Opsoclonus-Myoclonus Syndrome | 3% |
| 310 | Meningeal Carcinomatosis | 3% |
| 311 | Pharyngeal Neoplasms | 3% |
| 312 | granulosa cell tumor | 2.9% |
| 313 | Carcinoma, Ovarian Epithelial | 2.9% |
| 314 | Central Nervous System Cysts | 2.9% |
| 315 | Medulloblastoma | 2.9% |
| 316 | Bile Duct Neoplasms | 2.9% |
| 317 | gallbladder neoplasm | 2.9% |
| 318 | Intestinal Neoplasms | 2.9% |
| 319 | Penile Neoplasms | 2.9% |
| 320 | Prostatic Neoplasms | 2.9% |
| 321 | Stomach Neoplasms | 2.9% |
| 322 | Composite Lymphoma | 2.9% |
| 323 | Lymphoma | 2.9% |
| 324 | Polycythemia Vera | 2.8% |
| 325 | Corpus Luteum Cyst | 2.8% |
| 326 | Ovarian Cysts | 2.8% |
| 327 | Adenomatous Polyposis Coli | 2.8% |
| 328 | Leukemia, Plasma Cell | 2.8% |
| 329 | Adenoma, Acidophil | 2.8% |
| 330 | Ganglioneuroma | 2.8% |
| 331 | Glioma | 2.8% |
| 332 | Malignant Glioma | 2.8% |
| 333 | Mesoblastic Nephroma | 2.7% |
| 334 | Myelitis, Transverse | 2.7% |
| 335 | Basal cell carcinoma | 2.7% |
| 336 | Carcinoma, Papillary | 2.7% |
| 337 | Squamous cell carcinoma | 2.7% |
| 338 | Chondrosarcoma | 2.7% |
| 339 | Craniopharyngioma | 2.7% |
| 340 | Cystadenoma | 2.7% |
| 341 | leiomyosarcoma | 2.7% |
| 342 | liposarcoma | 2.7% |
| 343 | Mesothelioma | 2.7% |
| 344 | synovial sarcoma | 2.7% |
| 345 | Neuroectodermal Tumor, Melanotic | 2.7% |
| 346 | Angiomyolipoma | 2.7% |
| 347 | Clear Cell Sarcoma of Soft Tissue | 2.7% |
| 348 | Alveolar Soft Part Sarcoma | 2.7% |
| 349 | Neuroendocrine Tumors | 2.7% |
| 350 | Sarcoma, Myeloid | 2.7% |
| 351 | Carcinoma, Basal Cell | 2.7% |
| 352 | Basal Cell Nevus Syndrome | 2.6% |
| 353 | Adenoma | 2.6% |
| 354 | Ameloblastoma | 2.6% |
| 355 | Angiokeratoma | 2.6% |
| 356 | Carcinoma | 2.6% |
| 357 | Chordoma | 2.6% |
| 358 | Hemangioma | 2.6% |
| 359 | hemangiopericytoma | 2.6% |
| 360 | Lymphangioma | 2.6% |
| 361 | Mesenchymoma | 2.6% |
| 362 | Nevus | 2.6% |
| 363 | Teratoma | 2.6% |
| 364 | Hepatoblastoma | 2.6% |
| 365 | Mixed Tumor, Mullerian | 2.6% |
| 366 | Germinoma | 2.6% |
| 367 | Teratocarcinoma | 2.6% |
| 368 | Angiofibroma | 2.6% |
| 369 | Sarcoma | 2.6% |
| 370 | Epithelioma | 2.6% |
| 371 | Bladder Neoplasm | 2.5% |
| 372 | Kidney Neoplasm | 2.5% |
| 373 | Ureteral Neoplasms | 2.5% |
| 374 | Urethral Neoplasms | 2.5% |
| 375 | Supratentorial Neoplasms | 2.5% |
| 376 | Carcinoid Tumor | 2.5% |
| 377 | Endometrial Neoplasms | 2.5% |
| 378 | Neurilemmoma | 2.5% |
| 379 | Hutchinson's Melanotic Freckle | 2.5% |
| 380 | Melanoma, Amelanotic | 2.5% |
| 381 | Adrenocortical carcinoma | 2.5% |
| 382 | Choledochal Cyst | 2.5% |
| 383 | Peutz-Jeghers Syndrome | 2.4% |
| 384 | Cystadenocarcinoma | 2.3% |
| 385 | Fibrosarcoma | 2.3% |
| 386 | Osteosarcoma | 2.3% |
| 387 | Mucoepidermoid Carcinoma | 2.3% |
| 388 | Astrocytoma | 2.2% |
| 389 | Ependymoma | 2.2% |
| 390 | oligodendroglioma | 2.2% |
| 391 | Ganglioglioma | 2.2% |
| 392 | gliosarcoma | 2.2% |
| 393 | Anaplastic astrocytoma | 2.2% |
| 394 | Anaplastic Oligodendroglioma | 2.2% |
| 395 | Renal Cell Carcinoma | 2.2% |
| 396 | Papillary Renal Cell Carcinoma | 2.2% |
| 397 | Adenofibroma | 2.2% |
| 398 | Fibroadenoma | 2.2% |
| 399 | Malignant Fibrous Histiocytoma | 2.2% |
| 400 | Hypopharyngeal Neoplasms | 2.2% |
| 401 | Hypopharyngeal Cancer | 2.2% |
| 402 | Parotid Neoplasms | 2.1% |
| 403 | Prostatic Neoplasms, Castration-Resistant | 2.1% |
| 404 | Endometrial Stromal Sarcoma | 2.1% |
| 405 | Nelson Syndrome | 2.1% |
| 406 | Brain Stem Neoplasms | 2.1% |
| 407 | Malignant Carcinoid Syndrome | 2.1% |
| 408 | Pancreatic Pseudocyst | 2% |
| 409 | Plasmacytoma | 2% |
| 410 | Malignant histiocytosis | 2% |
| 411 | Lymphatic Metastasis | 2% |
| 412 | Neoplasms, Unknown Primary | 2% |
| 413 | Leukemic Infiltration | 2% |
| 414 | Histiocytic sarcoma | 2% |
| 415 | Neoplasm Micrometastasis | 2% |
| 416 | Bowen's Disease | 2% |
| 417 | Paraganglioma | 2% |
| 418 | Rhabdomyosarcoma | 2% |
| 419 | Giant Cell Tumor of Bone | 2% |
| 420 | Hydatidiform Mole | 1.9% |
| 421 | Glioblastoma | 1.9% |
| 422 | Neuroblastoma | 1.9% |
| 423 | Glioblastoma Multiforme | 1.9% |
| 424 | Carcinoma, Endometrioid | 1.9% |
| 425 | Lymphangioleiomyomatosis | 1.9% |
| 426 | Denys-Drash Syndrome | 1.9% |
| 427 | Nasopharyngeal carcinoma | 1.9% |
| 428 | Cecal Neoplasms | 1.9% |
| 429 | Duodenal Neoplasms | 1.9% |
| 430 | Choroid Plexus Papilloma | 1.9% |
| 431 | Dermatofibrosarcoma | 1.8% |
| 432 | Dermatofibrosarcoma Protuberans | 1.8% |
| 433 | Ganglioneuroblastoma | 1.8% |
| 434 | Tonsillar Neoplasms | 1.8% |
| 435 | Cerebellar Neoplasms | 1.8% |
| 436 | Neurofibrosarcoma | 1.7% |
| 437 | Adenocarcinoma | 1.7% |
| 438 | Carcinoma in Situ | 1.7% |
| 439 | Carcinoma, Transitional Cell | 1.7% |
| 440 | Phyllodes Tumor | 1.7% |
| 441 | Dysgerminoma | 1.7% |
| 442 | Hemangioendothelioma | 1.7% |
| 443 | Lipoma | 1.7% |
| 444 | Myoma | 1.7% |
| 445 | Myxoma | 1.7% |
| 446 | Neuroma | 1.7% |
| 447 | Papilloma | 1.7% |
| 448 | Pseudomyxoma Peritonei | 1.7% |
| 449 | Seminoma | 1.7% |
| 450 | Papillomatosis | 1.7% |
| 451 | Angiolipoma | 1.7% |
| 452 | Myelolipoma | 1.7% |
| 453 | Neoplasms, Bone Tissue | 1.7% |
| 454 | Neoplasms, Fibrous Tissue | 1.7% |
| 455 | Smooth Muscle Tumor | 1.7% |
| 456 | Adenomatosis, Pulmonary | 1.7% |
| 457 | Adenomatous Polyps | 1.7% |
| 458 | Carcinoma, Large Cell | 1.7% |
| 459 | Carcinoma, Small Cell | 1.7% |
| 460 | Desmoplastic Small Round Cell Tumor | 1.7% |
| 461 | Chondroma | 1.7% |
| 462 | Enchondroma | 1.7% |
| 463 | Hodgkin Disease | 1.7% |
| 464 | Lymphoma, Non-Hodgkin | 1.7% |
| 465 | Nasopharyngeal Neoplasms | 1.7% |
| 466 | Polycystic Ovary Syndrome | 1.7% |
| 467 | Pheochromocytoma | 1.7% |
| 468 | Alveolar rhabdomyosarcoma | 1.7% |
| 469 | Colorectal Neoplasms | 1.6% |
| 470 | Carcinoid Heart Disease | 1.6% |
| 471 | Xeroderma Pigmentosum | 1.5% |
| 472 | Appendiceal Neoplasms | 1.5% |
| 473 | Colonic Neoplasms | 1.5% |
| 474 | Rectal Neoplasms | 1.5% |
| 475 | Primary amyloidosis | 1.4% |
| 476 | Leukemia, Myelomonocytic, Chronic | 1.3% |
| 477 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.3% |
| 478 | Adenoid Cystic Carcinoma | 1.3% |
| 479 | fibroma | 1.3% |
| 480 | Fibromatosis | 1.3% |
| 481 | Osteoblastoma | 1.3% |
| 482 | Osteoma | 1.3% |
| 483 | Rhabdomyoma | 1.3% |
| 484 | Chondromatosis | 1.3% |
| 485 | Adenocarcinoma, Clear Cell | 1.3% |
| 486 | Cholangiocarcinoma | 1.3% |
| 487 | Cervical Intraepithelial Neoplasia | 1.3% |
| 488 | Hemangioblastoma | 1.3% |
| 489 | Lymphoma, Extranodal NK-T-Cell | 1.3% |
| 490 | Anus Neoplasms | 1.2% |
| 491 | Sigmoid Neoplasms | 1.2% |
| 492 | Mastocytosis | 1.1% |
| 493 | Sturge-Weber Syndrome | 1.1% |
| 494 | Cell Transformation, Viral | 1.1% |
| 495 | Gastrointestinal Stromal Tumors | 1.1% |
| 496 | Hemangioma, Cavernous | 1.1% |
| 497 | Waldenstrom Macroglobulinemia | 1.1% |
| 498 | Multiple Myeloma | 1.1% |
| 499 | Leukemia, T-Cell | 1.1% |
| 500 | Leukemia, B-Cell | 1.1% |
| 501 | neurofibroma | 1.1% |
| 502 | Lymphoma, Follicular | 1.1% |
| 503 | T-Cell Lymphoma | 1.1% |
| 504 | Mantle cell lymphoma | 1.1% |
| 505 | Fibromatosis, Aggressive | 1.1% |
| 506 | Fibromatosis, Abdominal | 1.1% |
| 507 | Klatskin Tumor | 1.1% |
| 508 | Mastocytoma | 1% |
| 509 | Mastocytosis, Systemic | 1% |
| 510 | Zollinger-Ellison syndrome | 1% |
| 511 | Leukemia, Myeloid, Chronic-Phase | 1% |
| 512 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 513 | Leukemia, Large Granular Lymphocytic | 0.8% |
| 514 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 515 | Lymphoma, T-Cell, Cutaneous | 0.8% |
| 516 | Lymphoma, AIDS-Related | 0.8% |
| 517 | Enteropathy-Associated T-Cell Lymphoma | 0.8% |
| 518 | Primary Effusion Lymphoma | 0.8% |
| 519 | Dupuytren Contracture | 0.7% |
| 520 | Urticaria Pigmentosa | 0.7% |
| 521 | Mycosis Fungoides | 0.7% |
| 522 | Lymphomatoid Papulosis | 0.7% |
| 523 | Plasmablastic lymphoma | 0.7% |
| 524 | Burkitt Lymphoma | 0.6% |
| 525 | Sezary Syndrome | 0.5% |
| 526 | Radicular Cyst | 0.5% |
